Fed Regist. 2014 Jun 10;79(111):33057-72.
The Food and Drug Administration (FDA or we) is issuing a final rule that adopts, with some modifications, the interim final rule (IFR) entitled "Current Good Manufacturing Practices, Quality Control Procedures, Quality Factors, Notification Requirements, and Records and Reports, for Infant Formula'' (February 10, 2014). This final rule affirms the IFR's changes to FDA's regulations and provides additional modifications and clarifications. The final rule also responds to certain comments submitted in response to the request for comments in the IFR.
美国食品药品监督管理局(FDA或我们)正在发布一项最终规则,该规则在做了一些修改后采用了题为《婴儿配方奶粉的现行良好生产规范、质量控制程序、质量因素、通知要求以及记录和报告》(2014年2月10日)的临时最终规则。本最终规则确认了临时最终规则对FDA法规所做的更改,并提供了更多的修改和澄清内容。最终规则还回应了针对临时最终规则征求意见请求所提交的某些评论。